There is no doubt that investors have shrugged off their usual capital market summer blahs to keep a close eye on the biotech sector. Overall they have liked what they have seen with biotech's leading companies benefitting from that enthusiasm, seeing their share prices soar. During that period, the BioWorld Biotech Blue Chip index hit a new high for the year, thanks to its strong 10 percent jump in value in August.